REMS Clock Ticking: Sponsors Grapple With Assessment Time Constraints

An FDA-convened panel of experts finds no single best question format for ascertaining patients’ and prescribers’ knowledge about drug risks learned through Risk Evaluation and Mitigation Strategies.